xmlui.ArtifactBrowser.SimpleSearch.title

xmlui.dri2xhtml.structural.pagination-info

Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days

Fjerstad, M; Lichtenberg, ES; Trussell, J; Cleland, K; Cullins, V (2013)

BACKGROUND: From 2001 to March 2006, Planned Parenthood Federation of America (Planned Parenthood) health centers throughout the United States provided medical abortions principally by a regimen of oral mifepristone, ...

Achievements of the FIGO Initiative for the Prevention of Unsafe Abortion and its Consequences in South-Southeast Asia.

Zaidi, S; Begum, F; Tank, J; Chaudhury, P; Yasmin, H; Dissanayake, M (International Federation of Gynecology and Obstetrics, 2014)

Since 2008, the FIGO Initiative for the Prevention of Unsafe Abortion and its Consequences has contributed to ensuring the substitution of sharp curettage by manual vacuum aspiration (MVA) and medical abortion in selected ...

First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review

Raymonda, Elizabeth; Shannonb, Caitlin; Weaverc, Mark; Winikoffa, Beverly (Elsevier, 2013)

Medical management of abortion, 2018

World Health Organization (World Health Organization, 2018)

La atención médica relacionada con el aborto abarca el tratamiento de diversas afecciones clínicas, incluido el aborto espontáneo e inducido (embarazos tanto viables como no viables), el aborto incompleto y la muerte fetal ...

A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries

Frye, Laura J; Kilfedder, Catherine; Blum, Jennifer; Winikoff, Beverly (Contraception, 2020-01)

IPPF y Gynuity Health Projects realizaron un análisis de lo que viene inserto en los empaques de misoprostol, mifepristona y combi-packs en diversos países con el fin de ver su precisión y si contenían información integral. ...